Dashboard
Manage Tickers

VTYXVentyx Biosciences, Inc.

Nasdaq ventyxbio.com


$ 1.94 $ -0.03 (-1.52 %)    

Tuesday, 20-Aug-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 480.29 $ -1.01 (-0.21 %)
DIA $ 408.54 $ -0.35 (-0.09 %)
SPY $ 558.65 $ -0.51 (-0.09 %)
TLT $ 98.68 $ 0.38 (0.39 %)
GLD $ 232.46 $ -1.26 (-0.54 %)
$ 1.97
$ 1.97
$ 1.94 x 466
-- x --
$ 1.92 - $ 1.98
$ 1.84 - $ 38.20
1,128,408
na
138.99M
$ 0.39
$ 6.41
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 02-27-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-23-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-23-2022 12-31-2021 10-K
12 11-18-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wells-fargo-maintains-overweight-on-ventyx-biosciences-lowers-price-target-to-11
Wells Fargo Maintains Overweight on Ventyx...
08/12/2024 17:48:34

Wells Fargo analyst Derek Archila maintains Ventyx Biosciences (NASDAQ:VTYX) with a Overweight and lowers the price target f...

canaccord-genuity-maintains-buy-on-ventyx-biosciences-lowers-price-target-to-14
Canaccord Genuity Maintains Buy on Ventyx ...
08/12/2024 12:00:04

Canaccord Genuity analyst Edward Nash maintains Ventyx Biosciences (NASDAQ:VTYX) with a Buy and lowers the price target from...

ventyx-biosciences-q2-eps-045-beats-057-estimate
Ventyx Biosciences Q2 EPS $(0.45) Beats $(...
08/08/2024 21:06:19

Ventyx Biosciences (NASDAQ:VTYX) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(...

hc-wainwright--co-reiterates-neutral-on-ventyx-biosciences-maintains-6-price-target
HC Wainwright & Co. Reiterates Neutral on ...
07/30/2024 11:52:03

HC Wainwright & Co. analyst Emily Bodnar reiterates Ventyx Biosciences (NASDAQ:VTYX) with a Neutral and maintains $6 pri...

dow-edges-lower-ventyx-biosciences-shares-plummet
Dow Edges Lower; Ventyx Biosciences Shares...
07/29/2024 18:31:47

why-bank-of-marin-bancorp-shares-are-trading-lower-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Bank of Marin Bancorp Shares Are Tradi...
07/29/2024 17:19:13

crude-oil-moves-lower-nls-pharmaceutics-shares-jump
Crude Oil Moves Lower; NLS Pharmaceutics S...
07/29/2024 16:03:54

ventyx-biosciences-inflammatory-bowel-disease-candidate-flunks-in-mid-stage-study-company-looks-for-partner-to-pursue-it-further
Ventyx Biosciences' Inflammatory Bowel Dis...
07/29/2024 15:03:01

Ventyx Biosciences stock down over 24% on Monday after Phase 2 trial results for Crohn's disease drug VTX958 did not meet p...

ventyx-biosciences-shares-resume-trade
Ventyx Biosciences Shares Resume Trade
07/29/2024 12:30:29

trading-halt-halt-status-updated-at-82500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:25:...
07/29/2024 12:25:04

ventyx-biosciences-announces-results-from-phase-2-trial-of-vtx958-did-not-meet-primary-endpoint-in-patients-with-moderately-to-severely-active-crohns-disease
Ventyx Biosciences Announces Results From ...
07/29/2024 12:02:09

trading-halt-halted-at-75500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:55:00 a.m. ET - ...
07/29/2024 11:55:03

hc-wainwright--co-reiterates-neutral-on-ventyx-biosciences-maintains-6-price-target
HC Wainwright & Co. Reiterates Neutral on ...
06/13/2024 10:41:28

HC Wainwright & Co. analyst Emily Bodnar reiterates Ventyx Biosciences (NASDAQ:VTYX) with a Neutral and maintains $6 pri...

sp-500-edges-lower-j-m-smucker-shares-surge-following-earnings-beat
S&P 500 Edges Lower; J. M. Smucker Shares ...
06/06/2024 18:45:57

why-g-iii-apparel-shares-are-trading-lower-by-13-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why G-III Apparel Shares Are Trading Lower...
06/06/2024 17:39:18

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
06/06/2024 16:31:11

crude-oil-jumps-2-lululemon-posts-upbeat-earnings
Crude Oil Jumps 2%; Lululemon Posts Upbeat...
06/06/2024 16:22:51

oppenheimer-maintains-outperform-on-ventyx-biosciences-lowers-price-target-to-10
Oppenheimer Maintains Outperform on Ventyx...
06/06/2024 13:30:55

Oppenheimer analyst Jeff Jones maintains Ventyx Biosciences (NASDAQ:VTYX) with a Outperform and lowers the price target from...

hc-wainwright--co-reiterates-neutral-on-ventyx-biosciences-maintains-6-price-target
HC Wainwright & Co. Reiterates Neutral on ...
06/06/2024 10:57:14

HC Wainwright & Co. analyst Emily Bodnar reiterates Ventyx Biosciences (NASDAQ:VTYX) with a Neutral and maintains $6 pri...

ventyx-biosciences-announces-preclinical-data-for-cns-penetrant-nlrp3-inhibitor-vtx3232-demonstrating-reversal-of-obesity-and-improvements-in-cardiometabolic-and-inflammatory-markers
Ventyx Biosciences Announces Preclinical D...
06/05/2024 20:01:55

VTX3232 demonstrated improvements in body weight, systemic inflammatory biomarkers and cardiometabolic parameters in diet-induc...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION